Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03093558 · ClinicalTrials.gov registry record · NA
Pilot Atrial Fibrillation Information Technology Trial
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT03093558 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 120 participants.
The verdict
NCT03093558, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
AF is associated with significant social and medical costs, including diminished quality of life (QOL) and increased health care utilization (HCU). This pilot study will enroll 200 adults with prevalent, non-valvular AF of ≤3 year's duration at University of Pittsburgh Medical Center (UPMC). The primary objective at present is to obtain extensive feasibility and pilot data in implementing the Embodied Conversational Agent (ECA) in concert with the Kardia (KAC) heart rhythm monitor.
Interventions
- BEHAVIORAL ECA/Kardia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2017-06-21 |
| Est. Completion | 2018-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03093558
The ClinicalTrials.gov registry entry for NCT03093558 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ECA/Kardia is the first listed.
NCT03093558 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03093558 about?
NCT03093558 is a clinical study titled "Pilot Atrial Fibrillation Information Technology Trial". AF is associated with significant social and medical costs, including diminished quality of life (QOL) and increased health care utilization (HCU). This pilot study will enroll 200 adults with prevalent, non-valvular AF of ≤3 year's duration at University of Pittsburgh Medical Center (UPMC). The pri...
What is the current status of trial NCT03093558?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2017-06-21. Estimated completion is 2018-06-30.
What interventions are being tested in trial NCT03093558?
The interventions under investigation include: ECA/Kardia (BEHAVIORAL).
Who is sponsoring clinical trial NCT03093558?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.